ACR GUIDELINES Bundle (free trial)

Ankylosing Spondylitis Guidelines

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/622885

Contents of this Issue

Navigation

Page 7 of 9

Treatment Table 8. SAARDs and Biologicals Slow-acting antirheumatic drugs (SAARDs) Apremilast Otezla ® Azathioprine generic Leflunomide Arava ® Methotrexate generic Sulfasalazine generic alidomide alomid ® Tofacitinib Xeljanz ® Tumor necrosis factor inhibitors (TNFi) Adalimumab Humira ® Certolizumab Cimzia ® Etanercept Enbrel ® Golimumab Simponi ® Infliximab Remicade ® Biologicals other than tumor necrosis factor inhibitors Abatacept Orencia ® Anakinra Kineret ® Rituximab Rituxan ® Tocilizumab Actemra ® Ustekinumab Stelara ® AS and: Advanced hip arthritis Severe kyphosis Acute iritis Recurrent iritis IBD Hip Arthroplasty Elective spine osteotomy Treatment by ophthalmologist At home topical GC Use infliximab or adalimumab over etanercept Use TNFi monoclonals over etanercept No preferred NSAID Consider at specialized centers Figure 3. Management of Stable AS

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - Ankylosing Spondylitis Guidelines